Back to CVE records
Medium 6.6Known exploited (CISA KEV)Published Dec 18, 2024

CVE-2024-12686Command Injection vulnerability in Remote Support(RS) & Privilege Remote Access (PRA)

Updated under an hour ago ()

Does this affect you?

It affects BeyondTrust Remote Support(RS) & Privileged Remote Access(PRA) and 2 other products. Add what you run to find out whether that includes you.

CISA lists it as known exploited since Jan 13, 2025; federal agencies had to remediate by Feb 3, 2025. Treat that date as your deadline.

A vulnerability has been discovered in Privileged Remote Access (PRA) and Remote Support (RS) which can allow an attacker with existing administrative privileges to inject commands and run as a site user.

CVSS
6.6 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-78
Known exploited
Added to CISA KEV Jan 13, 2025; federal remediation due Feb 3, 2025Apply mitigations per vendor instructions or discontinue use of the product if mitigations are unavailable.
EPSS (exploitation in the next 30 days)
13.70% (percentile 96)
Assigned by
BT
NVD analysis
Analyzed
Record last updated
Oct 21, 2025
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
BeyondTrust Remote Support(RS) & Privileged Remote Access(PRA)
beyondtrust:remote_support_rs_and_privileged_remote_access_pra (from the name)
through 24.3.1
CNA record
beyondtrust privileged_remote_access
beyondtrust:privileged_remote_access
through 24.3.1
NVD
beyondtrust remote_support
beyondtrust:remote_support
through 24.3.1
NVD

References

  • third-party-advisory, us-government-resource
  • vendor-advisory
  • us-government-resource

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.